Buscar
Mostrando ítems 1-10 de 68
Direct-acting antiviral agents for HCV-associated glomerular disease and the current evidence
(Molecular Diversity Preservation International, 2019-10)
Glomerular disease is an extra-hepatic manifestation of hepatitis C virus infection (HCV) and membranoproliferative glomerulonephritis is the most frequent glomerular disease associated with HCV. It occurs commonly in ...
History and progress of antiviral drugs: from acyclovir to direct-acting antiviral agents (DAAs) for Hepatitis C
(UANL. Facultad de Medicina, 2015)
Genetic diversity of NS3 protease from Brazilian HCV isolates and possible implications for therapy with direct-acting antiviral drugs
(Fundação Oswaldo Cruz. Instituto Oswaldo Cruz, 2017)
Effectiveness of generic direct-acting agents for the treatment of hepatitis C: systematic review and meta-analysis
(World Health Organization, 2020)
Hepatitis C virus molecular evolution: Transmission, disease progression and antiviral therapy
(Baishideng Publishing Group, 2014-11)
Hepatitis C virus (HCV) infection represents an important public health problem worldwide. Reduction of HCV morbidity and mortality is a current challenge owned to several viral and host factors. Virus molecular evolution ...
Complexation of a 1-indanone thiosemicarbazone with hydroxypropyl-beta-cyclodextrin enhances its activity against a Hepatitis C Virus surrogate model
(American Scientific Publishers, 2015-02)
The current standard of care of the infection by hepatitis C virus (HCV) is effective in a limited number of patients and the high cost hinders therapy affordability and compliance. In this context, the research of new ...
Atividade antiviral da quercetina sobre alguns vírus de importância veterináriaAntiviral activity of the quercetin against important virus of veterinary medicine
(Universidade Federal de ViçosaBRBioquímica e Biologia molecular de plantas; Bioquímica e Biologia molecular animalMestrado em Bioquímica AgrícolaUFV, 2015)
Hepatitis C Virus (HCV) clearance after treatment with direct-acting antivirals in human immunodeficiency virus (HIV)-HCV coinfection modulates systemic immune activation and HIV transcription on antiretroviral therapy
(Oxford University Press, 2020-05)
Background. Hepatitis C virus (HCV) coinfection among people with human immunodeficiency virus (HIV) might perturb immune function and HIV persistence. We aimed to evaluate the impact of HCV clearance with direct-acting ...